Differences in Dopaminergic Modulation to Motor Cortical Plasticity between Parkinson's Disease and Multiple System Atrophy

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Kawashima, Shoji ^a   Ueki, Yoshino ^a   Mima, Tatsuya ^b   Fukuyama, Hidenao ^b   Ojika, Kosei ^a   Matsukawa, Noriyuki ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARBIDOPA PLUS LEVODOPA; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; SELEGILINE; ANTIPARKINSON AGENT;

ADULT; AGED; AMPLITUDE MODULATION; ARTICLE; BRAIN FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DRUG RESPONSE; ELECTROSTIMULATION; EVOKED MUSCLE RESPONSE; FEMALE; HUMAN; MALE; MEDIAN NERVE; NERVE CELL PLASTICITY; NEUROMODULATION; PARKINSON DISEASE; PRIMARY MOTOR CORTEX; SHY DRAGER SYNDROME; TRANSCRANIAL MAGNETIC STIMULATION; DRUG EFFECTS; ELECTROMYOGRAPHY; MIDDLE AGED; MOTOR CORTEX; MULTIPLE SYSTEM ATROPHY; PATHOPHYSIOLOGY; PHYSIOLOGY; WRIST;

PARKINSONIA;

ADULT; AGED; ANTIPARKINSON AGENTS; ELECTRIC STIMULATION; ELECTROMYOGRAPHY; EVOKED POTENTIALS, MOTOR; FEMALE; HUMANS; LEVODOPA; MALE; MEDIAN NERVE; MIDDLE AGED; MOTOR CORTEX; MULTIPLE SYSTEM ATROPHY; NEURONAL PLASTICITY; PARKINSON DISEASE; TRANSCRANIAL MAGNETIC STIMULATION; WRIST;

EID: 84877040092     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0062515     Document Type: Article

References (52)

1. Charpier S, Deniau JM, (1997) In vivo activity-dependent plasticity at cortico-striatal connections: evidence for physiological long-term potentiation. Proc Natl Acad Sci U S A 94: 7036-7040.
2. Centonze D, Picconi B, Gubellini P, Bernardi G, Calabresi P, (2001) Dopaminergic control of synaptic plasticity in the dorsal striatum. Eur J Neurosci 13: 1071-1077.
3. Picconi B, Gardoni F, Centonze D, Mauceri D, Cenci A, et al. (2004) Abnormal Ca2+-Calmodulin-dependent protein kinase II function mediates synaptic and motor deficits in experimental parkinsonism. J Neurosci 24(23): 5283-5291.
4. Centonze D, Grande C, Saulle E, Martin AB, Gubellini P, et al. (2003) Distinct roles of D1 and D5 dopamine receptors in motor activity and striatal synaptic plasticity. J Neurosci 23: 8506-8512.
5. Yin HH, Mulcare SP, Hilario MR, Clouse E, Holloway T, et al. (2009) Dynamic reorganization of striatal circuits during the acquisition and consolidation of a skill. Nat Neurosci 12: 333-341.
6. Molina-Luna K, Pekanovic A, Rohrich S, Hertler B, Schubring-Giese M, et al. (2009) Dopamine in motor cortex is necessary for skill learning and synaptic plasticity. PLoS One 4: e7082.
7. Kawashima S, Ueki Y, Kato T, Matsukawa N, Mima T, et al. (2012) Changes in striatal dopamine release associated with human motor-skill acquisition. PLoS One 7: e31728.
8. Stefan K, Kunesch E, Cohen LG, Benecke R, Classen J, (2000) Induction of plasticity in the human motor cortex by paired associative stimulation. Brain 123 Pt 3: 572-584.
9. Stefan K, Kunesch E, Benecke R, Cohen LG, Classen J, (2002) Mechanisms of enhancement of human motor cortex excitability induced by interventional paired associative stimulation. J Physiol 543: 699-708.
10. Wolters A, Sandbrink F, Schlottmann A, Kunesch E, Stefan K, et al. (2003) A temporally asymmetric Hebbian rule governing plasticity in the human motor cortex. J Neurophysiol 89: 2339-2345.
11. Markram H, Lubke J, Frotscher M, Sakmann B, (1997) Regulation of synaptic efficacy by coincidence of postsynaptic APs and EPSPs. Science 275: 213-215.
12. Dan Y, Poo MM, (2004) Spike timing-dependent plasticity of neural circuits. Neuron 44: 23-30.
13. DeLong MR, (1990) Primate models of movement disorders of basal ganglia origin. Trend Neurosci 13: 281-285.
14. Smiley-Oyen AL, Worringham CJ, Cross CL, (2003) Motor learning processes in a movement-scaling task in olivopontocerebellar atrophy and Parkinson's disease. Exp Brain Res 152: 453-465.
15. Frith CD, Bloxham CA, Carpenter KN, (1986) Impairments in the learning and performance of a new manual skill in patines with Parkinson's disease. J Neurol Neurosurg Psychiatry 49: 661-668.
16. Schnider A, Butbrod K, Hess CW, (1995) Motion imagery in Parkinson's disease. Brain 118: 485-493.
17. Morgante F, Espay AJ, Gunraj C, Lang AE, Chen R, (2006) Motor cortex plasticity in Parkinson's disease and levodopa-induced dyskinesias. Brain 129: 1059-1069.
18. Ueki Y, Mima T, Kotb MA, Sawada H, Saiki H, et al. (2006) Altered plasticity of the human motor cortex in Parkinson's disease. Ann Neurol 59: 60-71.
19. Gilman S, Wenning GK, Low PA, Brooks DJ, Mathias CJ, et al. (2008) Second consensus statement on the diagnosis of multiple system atrophy. Neurology 71: 670-676.
20. Oppenheimer DR, Esiri MM (1992) Diseases of the basal ganglia, cerebellum and motor neurons. Greenfield's neuropathology Hume Adams J, Duchen LW, eds 5th ed.: 988-1045.
21. Papp MI, Kahn JE, Lantos PL, (1989) Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome). J Neurol Sci 94: 79-100.
22. Rossini PM, Barker AT, Berardelli A, Caramia MD, Caruso G, et al. (1994) Non-invasive electrical and magnetic stimulation of the brain, spinal cord and roots: basic principles and procedures for routine clinical application. Report of an IFCN committee. Electroencephalogr Clin Neurophysiol 91: 79-92.
23. Kita H, (1996) Glutamatergic and GABAergic postsynaptic responses of striatal spiny neurons to intrastriatal and cortical stimulation recorded in slice preparations. Neuroscience 70: 925-940.
24. Cherubini E, Herrling PL, Lanfumey L, Stanzione P, (1988) Excitatory amino acids in synaptic excitation of rat striatal neurones in vitro. J Physiol 400: 677-690.
25. Herrling PL, (1985) Pharmacology of the corticocaudate excitatory postsynaptic potential in the cat: evidence for its mediation by quisqualate- or kainate-receptors. Neuroscience 14: 417-426.
26. Brown P, (2003) Oscillatory nature of human basal ganglia activity: relationship to the pathophysiology of Parkinson's disease. Mov Disord 18: 357-363.
27. Brown P, Marsden CD, (1998) What do the basal ganglia do? Lancet 351: 1801-1804.
28. Van Laere K, Clerinx K, D'Hondt E, de Groot T, Vandenberghe W, (2010) Combined striatal binding and cerebral influx analysis of dynamic 11C-raclopride PET improves early differentiation between multiple-system atrophy and Parkinson disease. J Nucl Med 51: 588-595.
29. Brooks DJ, Seppi K, (2009) Proposed neuroimaging criteria for the diagnosis of multiple system atrophy. Mov Disord 24: 949-964.
30. Rinne JO, Laihinen A, Ruottinen H, Ruotsalainen U, Nagren K, et al. (1995) Increased density of dopamine D2 receptors in the putamen, but not in the caudate nucleus in early Parkinson's disease: a PET study with [11C]raclopride. J Neurol Sci 132: 156-161.
31. Huang YY, Simpson E, Kellendonk C, Kandel ER, (2004) Genetic evidence for the bidirectional modulation of synaptic plasticity in the prefrontal cortex by D1 receptors. Proc Natl Acad Sci U S A 101: 3236-3241.
32. Matsuda Y, Marzo A, Otani S, (2006) The presence of background dopamine signal converts long-term synaptic depression to potentiation in rat prefrontal cortex. J Neurosci 26: 4803-4810.
33. Kolomiets B, Marzo A, Caboche J, Vanhoutte P, Otani S, (2009) Background dopamine concentration dependently facilitates long-term potentiation in rat prefrontal cortex through postsynaptic activation of extracellular signal-regulated kinases. Cereb Cortex 19: 2708-2718.
34. Goto Y, Yang CR, Otani S, (2010) Functional and dysfunctional synaptic plasticity in prefrontal cortex: roles in psychiatric disorders. Biol Psychiatry 67: 199-207.
35. Nitsche MA, Kuo MF, Grosch J, Bergner C, Monte-Silva K, et al. (2009) D1-receptor impact on neuroplasticity in humans. J Neurosci 29: 2648-2653.
36. Nitsche MA, Monte-Silva K, Kuo MF, Paulus W, (2010) Dopaminergic impact on cortical excitability in humans. Rev Neurosci 21: 289-298.
37. Monte-Silva K, Liebetanz D, Grundey J, Paulus W, Nitsche MA, (2010) Dosage-dependent non-linear effect of L-dopa on human motor cortex plasticity. J Physiol 588: 3415-3424.
38. Huang YZ, Rothwell JC, Lu CS, Chuang WL, Chen RS, (2011) Abnormal bidirectional plasticity-like effects in Parkinson's disease. Brain 134: 2312-2320.
39. Miyatake S, Mochizuki H, Naka T, Ugawa Y, Tanabe H, et al. (2010) Brain volume analyses and somatosensory evoked potentials in multiple system atrophy. J Neurol 257: 419-425.
40. Gilman S, Koeppe RA, Junck L, Little R, Kluin KJ, et al. (1999) Decreased striatal monoaminergic terminals in multiple system atrophy detected with positron emission tomography. Ann Neurol 45: 769-777.
41. Osaki Y, Wenning GK, Daniel SE, Hughes A, Lees AJ, et al. (2002) Do published criteria improve clinical diagnostic accuracy in multiple system atrophy? Neurology 59: 1486-1491.
42. Sakurai K, Kawaguchi T, Kawai T, Ogino H, Hara M, et al. (2010) Usefulness of 3D-PRESTO imaging in evaluating putaminal abnormality in parkinsonian variant of multiple system atrophy. Neuroradiology 52: 809-814.
43. Ito S, Shirai W, Hattori T, (2009) Putaminal hyperintensity on T1-weighted MR imaging in patients with the Parkinson variant of multiple system atrophy. AJNR Am J Neuroradiol 30: 689-692.
44. Rolland Y, Verin M, Payan CA, Duchesne S, Kraft E, et al. (2011) A new MRI rating scale for progressive supranuclear palsy and multiple system atrophy: validity and reliability. J Neurol Neurosurg Psychiatry 82: 1025-1032.
45. Abbruzzese G, Marchese R, Trompetto C, (1997) Sensory and motor evoked potentials in multiple system atrophy: a comparative study with Parkinson's disease. Mov Disord 12: 315-321.
46. Eusebio A, Azulay JP, Witjas T, Rico A, Attarian S, (2007) Assessment of cortico-spinal tract impairment in multiple system atrophy using transcranial magnetic stimulation. Clin Neurophysiol 118: 815-823.
47. Kuhn AA, Grosse P, Holtz K, Brown P, Meyer BU, et al. (2004) Patterns of abnormal motor cortex excitability in atypical parkinsonian syndromes. Clin Neurophysiol 115: 1786-1795.
48. Cantello R, Tarletti R, Varrasi C, Cecchin M, Monaco F, (2007) Cortical inhibition in Parkinson's disease: new insights from early, untreated patients. Neuroscience 150: 64-71.
49. Rothwell J, (2007) Transcranial magnetic stimulation as a method for investigating the plasticity of the brain in Parkinson's disease and dystonia. Parkinsonism Relat Disord 13Suppl 3: S417-420.
50. Wu AD, Petzinger GM, Lin CH, Kung M, Fisher B, (2007) Asymmetric corticomotor excitability correlations in early Parkinson's disease. Mov Disord 22: 1587-1593.
51. Lefaucheur JP, (2005) Motor cortex dysfunction revealed by cortical excitability studies in Parkinson's disease: influence of antiparkinsonian treatment and cortical stimulation. Clin Neurophysiol 116: 244-253.
52. Marchese R, Trompetto C, Buccolieri A, Abbruzzese G, (2000) Abnormalities of motor cortical excitability are not correlated with clinical features in atypical parkinsonism. Mov Disord 15: 1210-1214.